Stress hyperglycemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Stress hyperglycemia is a medical term referring to transient elevation of the blood glucose due to the stress of illness. It usually requires no specific treatment and resolves spontaneously, but must be distinguished from various forms of diabetes mellitus.
It is often discovered when routine blood chemistry measurements in an ill patient reveal an elevated blood glucose. Blood glucose can be assessed either by a bedside ‘fingerstick’ glucose meter or plasma glucose as performed in a labarotory (the latter being more efficacious). A retrospective cohort study by the Mayo Clinic held that bedside glucometry was a reliable estimate of plasma glucose with a mean difference of 7.9 mg/dL, but still may not coincide with every individual PMID 15888855. The glucose is typically in the range of 140-300 mg/dl (7.8-16.7 mM) but occasionally can exceed 500 mg/dl (28 mM), especially if amplified by drugs or intravenous glucose. The blood glucose usually returns to normal within hours unless predisposing drugs and intravenous glucose are continued.
Stress hyperglycemia is especially common in patients with hypertonic dehydration and those with elevated catecholamine levels (e.g., after emergency department treatment of acute asthma with epinephrine). Steroid diabetes is a specific and prolonged form of stress hyperglycemia.
In some people, stress hyperglyemia may indicate a reduced insulin secretory capacity or a reduced sensitivity, and is sometimes the first clue to incipient diabetes. Because of this, it is occasionally appropriate to perform diabetes screening tests after recovery from an illness in which significant stress hyperglycemia occurred.
One of the most sweeping changes in intensive care unit and post-surgical care in recent years is the trend toward more aggressive treatment of hyperglycemia of all causes in hospitalized patients. A number of research studies of the last decade have demonstrated that even mildly elevated blood glucose levels (110 mg/dL or 6.1 mmol/L) in a hospital intensive care unit (ICU) can measurably increase the morbidity and mortality of such patients. According to a randomized control trial (RCT) of over 1500 surgical intensive care unit (ICU) patients, controlling patients’ blood glucose below 110 mg/dL or 6.1 mmol/L significantly decreased mortality from 8% with conventional treatment to 4.6% PMID 11794168. Intensive insulin therapy also decreased bloodstream infections by 46%, acute renal failure requiring dialysis or hemofiltration by 41%, the median number of red-cell transfusions by 50%, and critical-illness polyneuropathy by 44%. A subsequent RCT of 1200 medical ICU patients found that intensive insulin therapy significantly reduced morbidity but not mortality among all patients in the medical ICU PMID 16452557. It is becoming increasingly common to treat hospital patients with "stress hyperglycemia" aggressively, usually with insulin.
References
Finkielman J, Oyen L, Afessa B (2005). "Agreement between bedside blood and plasma glucose measurement in the ICU setting". Chest 127 (5): 1749-51. PMID 15888855.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001). "Intensive insulin therapy in the critically ill patients". N Engl J Med 345 (19): 1359-67. PMID 11794168.
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters P, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006). "Intensive insulin therapy in the medical ICU". N Engl J Med 354 (5): 449-61. PMID 16452557.
WikiDoc Research Resources for Stress hyperglycemia | |
|---|---|
| Articles on Stress hyperglycemia | Most recent articles on Stress hyperglycemia • Most cited articles on Stress hyperglycemia • Review articles on Stress hyperglycemia • Articles on Stress hyperglycemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Stress hyperglycemia | Powerpoint slides on Stress hyperglycemia • Images of Stress hyperglycemia • Photos of Stress hyperglycemia • Podcasts & MP3s on Stress hyperglycemia • Videos on Stress hyperglycemia |
| Evidence Based Medicine Regarding Stress hyperglycemia | Cochrane Collaboration on Stress hyperglycemia • Bandolier on Stress hyperglycemia • TRIP on Stress hyperglycemia |
| Cost Effectiveness of Stress hyperglycemia | Cost Effectiveness of Stress hyperglycemia |
| Clinical Trials Involving Stress hyperglycemia | Ongoing Trials on Stress hyperglycemia at Clinical Trials.gov • Trial results on Stress hyperglycemia • Clinical Trials on Stress hyperglycemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Stress hyperglycemia | US National Guidelines Clearinghouse on Stress hyperglycemia • NICE Guidance on Stress hyperglycemia • NHS PRODIGY Guidance • FDA on Stress hyperglycemia • CDC on Stress hyperglycemia |
| Textbook Information on Stress hyperglycemia | Books and Textbook Information on Stress hyperglycemia |
| Pharmacology Resources on Stress hyperglycemia | Dosing of Stress hyperglycemia • Drug interactions with Stress hyperglycemia • Side effects of Stress hyperglycemia • Allergic reactions to Stress hyperglycemia • Overdose information on Stress hyperglycemia • Carcinogenicity information on Stress hyperglycemia • Stress hyperglycemia in pregnancy • Pharmacokinetics of Stress hyperglycemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Stress hyperglycemia | Genetics of Stress hyperglycemia • Pharmacogenomics of Stress hyperglycemia • Proteomics of Stress hyperglycemia |
| Newstories on Stress hyperglycemia | Stress hyperglycemia in the news • Be alerted to news on Stress hyperglycemia • News trends on Stress hyperglycemia |
| Commentary on Stress hyperglycemia | Blogs on Stress hyperglycemia |
| Patient Resources on Stress hyperglycemia | Patient resources on Stress hyperglycemia • Discussion groups on Stress hyperglycemia • Patient Handouts on Stress hyperglycemia • Directions to Hospitals Treating Stress hyperglycemia • Risk calculators and risk factors for Stress hyperglycemia |
| Healthcare Provider Resources on Stress hyperglycemia | Symptoms of Stress hyperglycemia • Causes & Risk Factors for Stress hyperglycemia • Diagnostic studies for Stress hyperglycemia • Treatment of Stress hyperglycemia |
| Continuing Medical Education (CME) Programs on Stress hyperglycemia | CME Programs on Stress hyperglycemia |
| International Resources on Stress hyperglycemia | Stress hyperglycemia en Espanol • Stress hyperglycemia en Francais |
| Business Resources on Stress hyperglycemia | Stress hyperglycemia in the Marketplace • Patents on Stress hyperglycemia |
| Informatics Resources on Stress hyperglycemia | List of terms related to Stress hyperglycemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
